222401-05-0

Basic information

• Product Name: 6-Methoxy-2-(4-methoxyphenyl)-3-(4-[1-benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene
• Synonyms: 6-Methoxy-2-(4-methoxyphenyl)-3-(4-[1-benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene
• CAS NO: 222401-05-0
• Molecular Weight: 549.69
• Mol File: 222401-05-0.mol

Chemical Properties

• CAS DataBase Reference: 6-Methoxy-2-(4-methoxyphenyl)-3-(4-[1-benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Methoxy-2-(4-methoxyphenyl)-3-(4-[1-benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene(222401-05-0)
• EPA Substance Registry System: 6-Methoxy-2-(4-methoxyphenyl)-3-(4-[1-benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene(222401-05-0)

Safety Data

• Hazardous Substances Data: 222401-05-0(Hazardous Substances Data)

Upstream product

• 63676-19-7 [6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophen-3-yl](4-hydroxyphenyl)methanone 
• 775-15-5 1-benzyl-3-pyrrolidinol 

Downstream Products

• 222401-17-4 6-Hydroxy-2-(4-Hydroxyphenyl)-3-(4-[1-Benzylpyrrolidin-3-oxy]benzoyl)benzo[b]thiophene 

Relevant articles and documents

Benzothiophenes for treating estrogen deficiency

This invention is related to novel benzothiophene compounds of formula I: where R, R1, R2, X and m are as defined in the specification, which are useful for the inhibition of the various medical conditions associated with postmenopausal syndrome, as well

Benzothiophenes

This invention is related to novel benzothiophene compounds of formula I: which are useful for the inhibition of the various medical conditions associated with postmenopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus, and cervix. The present invention further relates to pharmaceutical formulations of compounds of formula I.